Skip to main content
. 2017 Jun;38(6):1193–1199. doi: 10.3174/ajnr.A5157

Table 4:

Initial posttreatment versus subsequent follow-up

Combined Primary and Nodes Posttreatment Follow-Up
NI-RADS 1 5.7% (5/88) 3.4% (15/440)
NI-RADS 2 20.0% (4/20) 15.8% (6/38)
NI-RADS 3 50.0% (4/8) 62.5% (15/24)
Combined, all categories 11.2% (13/116) 7.2% (36/502)